RxDoctor Payments Data

Robert Koch, MD

Family Medicine · Boonville, MONPI 1568409142

Payments from drug & device makers

$860in general payments, 2019–2025

Across 65 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$151
  • Johnson & Johnson$143
  • Amgen$118
  • Sumitomo Pharma America, Inc.$63
  • E.r. Squibb & Sons, L.L.C.$56
  • Amarin Pharma, Inc.$43
  • plus $287 from 12 others

What the payments were for

  • Food & beverage$85599%
  • Education$51%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$860 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$103,298
Medicare patients
307
Services billed
1,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban357$178,263
OzempicSemaglutide92$127,974
JanuviaSitagliptin Phosphate98$98,007
Breo ElliptaFluticasone/Vilanterol107$61,702
XareltoRivaroxaban144$60,820
FarxigaDapagliflozin Propanediol64$54,692
Austedo XrDeutetrabenazine22$45,133
TrulicityDulaglutide35$35,576
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$34,921
MyrbetriqMirabegron83$23,925
Combivent RespimatIpratropium/Albuterol Sulfate42$21,153
JardianceEmpagliflozin40$20,028
Tresiba Flextouch U-100Insulin Degludec32$15,123
Spiriva HandihalerTiotropium Bromide25$12,846
Incruse ElliptaUmeclidinium Bromide31$12,820

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$151$178,263357 claims
Novo NordiskOzempic, Levemir$29$132,310106 claims
MerckJanuvia, Janumet Xr$13$104,206109 claims
AstraZenecaFarxiga, Symbicort$33$67,093100 claims
Johnson & JohnsonXarelto$143$60,820144 claims
Lilly USA, LLCTrulicity$12$35,57635 claims
Astellas Pharma US IncMyrbetriq$36$23,92583 claims
AbbVieLinzess, Restasis$19$19,16625 claims
NovartisEntresto$13$8,10213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Boonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →